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ABSTRACT
Disseminated toxoplasmosis is a life-threatening disease in immunocompromised individuals. Infection is contracted 
from handling contaminated soil, cat litter, or through the consumption of contaminated water or food. It is the third 
most common lethal foodborne infection in the United States. In transplant patients, most cases occur as a result of 
reactivation of a latent infection resulting from immunosuppression. We present a case of disseminated toxoplasmosis 
diagnosed at the time of autopsy. This case emphasizes the importance of maintaining a high index of clinical suspicion 
and active disease surveillance in this era of sophisticated diagnostic testing. 
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INTRODUCTION
Toxoplasmosis is caused by the protozoan 
parasite Toxoplasma gondii. It is a zoonotic disease 
with worldwide distribution and an opportunistic 
pathogen primarily infecting immunocompromised 
individuals. Global prevalence is 10-80%,1 but clinically 
significant disease is uncommon. In the United States, 
approximately 225,000 cases of toxoplasmosis are 
reported annually, resulting in 750 deaths, which 
makes T. gondii the third most common cause of lethal 
foodborne infection in the United States.2
In organ transplant recipients, toxoplasmosis 
is most commonly a result of reactivation of latent 
infection; however, donor-transmitted infection or de 
novo infection are known to occur. In these patients, 
the most common presentations are retinochoroiditis, 
cerebritis, pneumonitis, myocarditis, and disseminated 
disease. We describe the autopsy findings in a renal 
transplant recipient with disseminated toxoplasmosis 
diagnosed at autopsy.
CASE REPORT
A 49-year-old Caucasian male with a past medical 
history of end stage renal disease secondary to 
diabetes mellitus, status post deceased-donor kidney 
allograft and on immunosuppression with prednisone, 
tacrolimus and mycophenolate mofetil; hypertension, 
obesity, peripheral vascular disease, and anemia 
presented to the emergency department 6 weeks 
post-transplantation procedure with dehiscence 
of his right lower quadrant surgical wound. Upon 
admission, the patient was noted to be acidotic, 
hypovolemic, hyperkalemic, and in respiratory distress, 
necessitating intubation. He was urgently taken to 
the operating room for debridement and closure of 
the wound which he tolerated well; however, during 
the course of his hospital stay he exhibited altered 
mental status with continued respiratory distress. 
Despite receiving high flow supplemental oxygen, 
oxygen saturations were continually in the low 
90% range. He also exhibited marked leukocytosis 
with a white blood cel l  count of 26,400/mm3 
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(normal range [NR]: 4000-11000/mm3). Blood and 
urine cultures yielded no growth. CMV serology by 
PCR was negative with quantitative CMV DNA less than 
250 CPY/ml (NR: < 250 CPY/ml). Toxoplasma serology 
was not ordered and was not done as a pre-transplant 
work up. His arterial partial oxygen pressure became 
critically low at 35.4 mmHg (NR: 80-100 mmHg) and 
he was intubated, however, there was no improvement 
of the respiratory status, and the patient experienced 
cardiorespiratory arrest. Resuscitative efforts were 
unsuccessful and the patient was pronounced 
deceased with a postmortem examination requested 
and subsequently performed.
AUTOPSY FINDINGS
Most significant finding at the autopsy was 
disseminated toxoplasmosis with T.gondii identified 
within the bilateral lungs, heart, liver, pancreas, bilateral 
native kidneys, transplanted kidney, spleen, bone 
marrow, and central nervous system (Figure 1 and 2). 
Figure 1. Photomicrographs of the heart showing the T. gondii cyst (arrowhead and inset) (A – H&E, 400X; 
B – T.gondii stain 1000X).
Figure 2. Photomicrographs of the brain showing the T. gondii cysts in the Midbrain (A – H&E, 400X) and the 
Brainstem (B – H&E, 400X).
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Figure 3. Photomicrographs of the lungs exhibiting necrotizing bronchopneumonia (A – H&E, 100X). T. gondii cysts 
in Lungs (B-D, B-C – H&E, 400X and 1000X respectively, D – T. gondii stain 400X).
Additional findings included cardiomegaly with 
left ventricular hypertrophy and moderate calcific 
atherosclerotic coronary artery disease; bilateral, 
multifocal necrotizing bronchopneumonia secondary 
to T.gondii (Figure 3); and hepatosplenomegaly.
Immediate cause of death was cardiopulmonary 
arrest secondary to respiratory distress. Underlying cause 
was disseminated toxoplasmosis as a consequence of 
medical immunosuppression. Manner of death was 
natural.
DISCUSSION
T. gondii infection in renal transplant patients is 
rare, but can be rapidly progressive and life threatening. 
Missed diagnosis is one of the causes of high mortality. 
Wulf et al.3 found that 43% of cases were diagnosed 
at autopsy. Recent data in this regard are not available; 
however, our case indicates that clinically missed 
toxoplasmosis in the setting of post-transplant 
immunosuppression remains a concern today.
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T. gondii has two distinct life cycles. The sexual 
cycle occurs only in cats which are the definitive 
host. The asexual cycle occurs in other mammals, 
including humans and some avian species. In humans, 
infection occurs by ingestion of oocysts from handling 
contaminated soil or cat l itter or through the 
consumption of contaminated water or undercooked 
meat of infected animals. Our patient, in fact, did 
own a cat.
Clinical presentation is nonspecific. Fever occurs 
frequently, followed by flu like symptoms, lymphadenopathy, 
visual changes, pneumonia, and neurologic manifestations 
such as headache, seizures, altered mental status, and 
focal neurologic deficits. Our patient exhibited altered 
mental status and severe respiratory distress which 
correlated with the autopsy findings of bilateral, multifocal 
necrotizing bronchopneumonia and central nervous 
system involvement.
Diagnosis is confirmed by serology, tissue biopsy, 
or PCR assay for the presence of T. gondii DNA. 
Serology is of limited value in the setting of reactivation 
of a latent infection. Moreover, interpretation of 
serologic tests in immunocompromised patients is not 
straightforward and absence of specific antibodies 
does not exclude active disease. The duration for 
which T. gondii can be detected in blood is not clear. 
Additionally, T. gondii is only present intermittently in 
cerebrospinal fluid for unknown reasons,4 which limits 
the use of PCR assay. However, it is found to be useful 
in acute primary infection.3 Tissue biopsy is not only 
an invasive procedure, but is also limited by sampling 
artifact. Maintaining a high index of clinical suspicion 
is therefore the cornerstone of proper diagnosis. 
Toxoplasmosis should be high on the list of differential 
diagnoses in a post-transplant patient with respiratory 
distress and culture negative sepsis.
Imaging studies are valuable in cerebral and 
pulmonary toxoplasmosis. MRI is superior to CT 
scan in cerebral toxoplasmosis. Toxoplasma lesions 
on MRI appear as high-signal abnormalities on 
T2-weighted studies and demonstrate a rim of 
enhancement surrounding the edema on T1-weighted, 
contrast-enhanced images. CT scans show multiple 
bilateral cerebral lesions. Chest radiographs in 
toxoplasma pneumonia usually demonstrate interstitial 
infiltrate. In our patient, a CT of the head showed 
asymmetric decreased attenuation in left frontal 
lobe white matter suggestive of microangiopathy or 
encephalomalacia. No acute intracranial abnormality or 
evidence pointing to T. gondii was noted. Chest x-ray 
showed mild to moderate prominence of the pulmonary 
vessels, interstitial infiltrates, and changes consistent 
with atelectasis.
For more prevalent infections, such as HIV, HBV 
and HCV there is general agreement with respect 
to pre-transplant screening guidelines. Regarding 
screening for other infectious agents, including 
T. gondii, each transplant center follows different 
protocols. Many transplant centers screen both 
donors and recipients for anti-Toxoplasma antibody, 
especially in cases of heart transplant.5 Screening of 
donors and recipients for anti-Toxoplasma antibody 
is not routinely performed for noncardiac transplants, 
but is part of the screening panel at some transplant 
centers.5 Seropositivity is not a contraindication to 
transplantation but allows for administration of 
appropriate prophylaxis.5 Our transplant center does 
not perform toxoplasma screening routinely.
Moreover, trimethoprim-sulfamethoxazole 
prophylaxis against Pneumocystis jiroveci is thought 
to be effective in preventing toxoplasmosis.6 For these 
reasons routine pre-transplant screening for T. gondii 
is not recommended in kidney transplant donors 
and recipients, especially in low prevalence areas. 
Toxoplasma serology was neither performed on 
our patient nor the donor. The patient was initially 
started on trimethoprim-sulfamethoxazole prophylaxis; 
however, it was discontinued due to resultant 
hyperkalemia.
Pyrimethamine is the mainstay of treatment. 
The most effective available therapeutic combination is 
pyrimethamine plus sulfadiazine or trisulfapyrimidines. 
Unfortunately, our patient expired before treatment 
could be initiated.
This  case emphasizes the importance of 
maintaining a high index of clinical suspicion and 
active disease surveillance in this era of sophisticated 
diagnostic testing.
The manuscript is in accordance with St. 
John Hospital and Medical Center review board’s 
recommendations.
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